Centre for Biochemical Pharmacology: Recent submissions
Now showing items 81-100 of 333
-
Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction.
(2022-03)Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence worldwide, already accounting for at least half of all heart failure (HF). As most patients with HFpEF are obese with metabolic syndrome, ... -
S25 The impact of COVID-19 on the UK severe asthma population
(BMJ, 2021-02) -
Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study
(2021)<h4>Summary</h4> <h4>Background</h4> There are currently no effective pharmacological or non-pharmacological interventions for Long-COVID. To identify potential therapeutic targets, we focussed on previously described four ... -
Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis.
(National Academy of Sciences, 2021-09-21)Rheumatoid arthritis (RA) carries a twofold increased incidence of heart failure with preserved ejection fraction, accompanied by diastolic dysfunction, which can lead to death. The causes of diastolic dysfunction are ...